Consistent with this finding, MMC failed to upregulate PD-L1 expression in the NSCLC cells in the presence of nifuroxazide (an inhibitor preventing the activation of STAT3; Fig. 6i–l). This evidence concerns the gene STAT3 and non-small cell lung carcinoma.